US medical implant demand will rise 9.3 percent annually through 2011. Cardiac implants will remain the top-selling group, led by stents and defibrillators. Bone cement, tissue and spinal implants will pace gains in the orthopedic segment. Other fast-growing types include neurological stimulators, cochlear devices and gastric bands.
This study analyzes the $27.9 billion US medical implant industry. It presents historical demand data for the years 1996, 2001 and 2006, and forecasts for 2011 and 2016 by material and component (e.g., microelectronics, specialty metals, polymers, elastomers, ceramics, collagen) and implant type (e.g., cardiac, orthopedic, neurological, ophthalmic, breast, drug).
The study also considers market environment factors, details industry structure, evaluates company market share and profiles 26 major players including Medtronic, Johnson & Johnson, Boston Scientific, Stryker, Zimmer, St. Jude Medical, Synthes, Abbott Laboratories, Biomet, and Smith & Nephew.